Tscan Therapeutics Inc Stock Performance
as on October 23, 2025 at 9:40 pm IST
Day's Low
Day's High
$2.25$2.34
1.32%
Downside
2.63%
Upside
52 Week's Low
52 Week's High
$1.02$6.2355.26%
Downside
173.03%
Upside
Tscan Therapeutics Inc share price movements today
- Previous Close
- $2.24
- Open
- $2.31
- Volume
- 215.8K
- Day's Low - High
- $2.25 - $2.34
- 52 Week Low - High
- $1.02 - $6.23
Tscan Therapeutics Inc Historical Returns
- 1 Month Return
- + 24.44 %
- 3 Month Return
- + 20.43 %
- 1 Year Return
- -55.99 %
- 3 Year Return
- -22.22 %
- 5 Year Return
- 0 %
Tscan Therapeutics Inc Stock Fundamentals & Key Indicators
Check Tscan Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$140.7M
EPS (TTM)
-1.2496
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.63
Industry PE ratio
0PEG Ratio
0EBITDA
-141.1M
Revenue (TTM)
7.0M
Profit Margin
0.00%
Return On Equity TTM
-63.33%
Tscan Therapeutics Inc Stock Valuation
Track how Tscan Therapeutics Inc P/E has moved over time to understand its valuation trends.
Tscan Therapeutics Inc in the last 5 years
Lowest (-7.50x)
June 30, 2024
Industry (0.00x)
October 23, 2025
Today (-2.63x)
October 23, 2025
Highest (-0.45x)
March 31, 2022
Today’s Price to Earnings Ratio: -2.63x
Tscan Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Tscan Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $140.7M | NA | -2.63 | 0.00% | |
| BUY | $63.1B | 252.62% | -505.15 | -12.96% | |
| NA | $35.3B | NA | NA | -3.89% | |
| BUY | $109.3B | 101.55% | 30.36 | 31.86% | |
| BUY | $61.3B | 0.85% | 14.6 | 31.37% |
Stock Returns calculator for Tscan Therapeutics Inc Stock including INR - Dollar returns
The Tscan Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Tscan Therapeutics Inc investment value today
Current value as on today
₹49,446
Returns
Returns from Tscan Therapeutics Inc Stock
Dollar Returns*
₹4,653 (+4.65%)
Analyst Recommendation on Tscan Therapeutics Inc Stock
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Tscan Therapeutics Inc. Average target price of $8.57
Tscan Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Tscan Therapeutics Inc.
What analysts predicted
73.4%UPSIDE
Target Price
$8.57
Current Price
$2.28
Analyzed by
12 Analysts
Target
$8.57
Tscan Therapeutics Inc target price $8.57, a slight upside of 73.4% compared to current price of $2.28. According to 12 analysts rating.
Tscan Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Tscan Therapeutics Inc Stock has increased by 78% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:78% versus previous 30 day period
Tscan Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Tscan Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Tscan Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Tscan Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Insights on Tscan Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 665.0K → 3.07M (in $), with an average increase of 49.4% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 133.8% return, outperforming this stock by 156.0%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 57.7% return, outperforming this stock by 113.7%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, -34.12M → -36.95M (in $), with an average decrease of 8.3% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, TCRX stock has moved down by -9.7%
About Tscan Therapeutics Inc
| Organisation | Tscan Therapeutics Inc |
| Headquarters | 830 Winter Street, Waltham, MA, United States, 02451 |
| CEO | Dr. Gavin MacBeath Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Tscan Therapeutics Inc
Name | Title |
|---|---|
Dr. Chrystal U. Louis M.D., M.P.H. | Chief Medical Officer |
Mr. Tomasz Kula Ph.D. | Co-Founder & Member of Advisory Board |
Dr. Justin McCue Ph.D. | Chief Technology Officer |
Dr. Shrikanta Chattopadhyay M.D. | Senior VP & Head of Translational Medicine |
Dr. Gavin MacBeath Ph.D. | CEO & Director |
Mr. Jason A. Amello CPA | CFO & Treasurer |
Dr. Zoran Zdraveski J.D., Ph.D. | Chief Legal & Strategy Officer and Company Secretary |
Ms. Ann Hargraves | Senior Vice President of Human Resources |
Dr. Stephen J. Elledge Ph.D. | Co-Founder & Chairman of Scientific Advisory Board |
Mr. Leiden Dworak M.B.A. | Principal Accounting Officer |
FAQs
What is Tscan Therapeutics Inc share price today?
Tscan Therapeutics Inc share price today is $2.28 as on . Tscan Therapeutics Inc share today touched a day high of $2.34 and a low of $2.25.
What is the 52 week high and 52 week low for Tscan Therapeutics Inc share?
Tscan Therapeutics Inc share touched a 52 week high of $6.23 on and a 52 week low of $1.02 on . Tscan Therapeutics Inc stock price today i.e. is trending at $2.28,which is 63.37% down from its 52 week high and 123.53% up from its 52 week low.
What is Tscan Therapeutics Inc's market capitalisation today?
Tscan Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Tscan Therapeutics Inc Stock (TCRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Tscan Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tscan Therapeutics Inc Shares that will get you 0.6579 shares as per Tscan Therapeutics Inc share price of $2.28 per share as on October 23, 2025 at 9:40 pm IST.
What is the minimum amount required to buy Tscan Therapeutics Inc Stock (TCRX) from India?
Indian investors can start investing in Tscan Therapeutics Inc (TCRX) shares with as little as ₹87.835 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.35 in Tscan Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Tscan Therapeutics Inc share’s latest price of $2.28 as on October 23, 2025 at 9:40 pm IST, you will get 4.3860 shares of Tscan Therapeutics Inc. Learn more about
fractional shares .